Shattuck Labs, Inc.
HETERODIMERIC PROTEINS FOR MODULATING GAMMA DELTA T CELLS
Last updated:
Abstract:
The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Status:
Application
Type:
Utility
Filling date:
3 Jun 2020
Issue date:
1 Oct 2020